CoChat

The diverse and expanding role of mass spectrometry in structural and molecular biology

Open access
Lössl, Philip, van de Waterbeemd, Michiel, Heck, Albert JR · 2016 · The EMBO Journal

The DOI matches its Crossref record; 270 of the 271 references it cites were found in a registry or an index.

Abstract

The emergence of proteomics has led to major technological advances in mass spectrometry (MS). These advancements not only benefitted MS-based high-throughput proteomics but also increased the impact of mass spectrometry on the field of structural and molecular biology. Here, we review how state-of-the-art MS methods, including native MS, top-down protein sequencing, cross-linking-MS, and hydrogen-deuterium exchange-MS, nowadays enable the characterization of biomolecular structures, functions, and interactions. In particular, we focus on the role of mass spectrometry in integrated structural and molecular biology investigations of biological macromolecular complexes and cellular machineries, highlighting work on CRISPR-Cas systems and eukaryotic transcription complexes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.201694818

Cites

270 of 270 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 MS‐based molecular and structural biology reaches out over all cellular compartments and kingdoms of life Shown are exemplary results of studies that employed biomolecular MS techniques. Clockwise (from bottom left): membrane interactions of the endosomal Vps34 complex (Rostislavleva et al, 2015), conformational dynamics of the ABC transporter P‐glycoprotein (Marcoux et al, 2013), the organization of the nuclear pore complex scaffold (Bui et al, 2013), nucleotide binding to the p97 ATPase (Schuller et al, 2016), the interfaces of the H2A‐H2B‐Nap1 histone‐chaperone complex (D'Arcy et al, 2013), the structure of the 55S mitochondrial ribosome (Greber et al, 2015), the norovirus assembly pathway (Uetrecht et al, 2010a), the exosome complex topology (Hernández et al, 2006; Synowsky et al, 2006; Shi et al, 2015), and the architecture of the dynein cofactor dynactin (Urnavicius et al, 2015). Structural snapshots adapted from the referenced publications with permission.
Figure 1 MS‐based molecular and structural biology reaches out over all cellular compartments and kingdoms of life Shown are exemplary results of studies that employed biomolecular MS techniques. Clockwise (from bottom left): membrane interactions of the endosomal Vps34 complex (Rostislavleva et al, 2015), conformational dynamics of the ABC transporter P‐glycoprotein (Marcoux et al, 2013), the organization of the nuclear pore complex scaffold (Bui et al, 2013), nucleotide binding to the p97 ATPase (Schuller et al, 2016), the interfaces of the H2A‐H2B‐Nap1 histone‐chaperone complex (D'Arcy et al, 2013), the structure of the 55S mitochondrial ribosome (Greber et al, 2015), the norovirus assembly pathway (Uetrecht et al, 2010a), the exosome complex topology (Hernández et al, 2006; Synowsky et al, 2006; Shi et al, 2015), and the architecture of the dynein cofactor dynactin (Urnavicius et al, 2015). Structural snapshots adapted from the referenced publications with permission.CC BY-NC-ND · PubMed Central
Figure 2 The broad scope of complementary biomolecular MS methods In protein‐centric approaches (top), non‐digested biomolecules or biomolecular assemblies are analyzed. Typically, the sample is injected into the mass spectrometer via electrospray ionization using a conductive borosilicate capillary, as symbolized in the top panel. After injection, the analyte structure and composition can be further evaluated by several gas‐phase manipulation strategies, some of which are schematically depicted. Ion mobility separation prior to mass measurement renders information about the analyte's conformation and shape. Dissociation of a non‐denatured biomolecular assembly by collisional activation (symbolized as an explosion cartoon) allows inferring its stoichiometry and topological aspects. Mass selection can be performed for both denatured and non‐denatured analytes, enabling the focused analysis of a specific species such as a protein isoform that carries a certain mutation or a defined number of PTMs. After mass selection, proteoform sequencing can be performed by fragmenting the protein isoforms in the gas phase (symbolized as an explosion cartoon), which allows to determine their amino acid sequence and thus locate mutated and/or modified residues. In peptide‐centric approaches (bottom), proteins or protein complexes are manipulated in solution by traditional biochemical methods, such as chemical cross‐linking, limited proteolysis, or surface labeling. Subsequently, the proteins are digested into peptides and liquid chromatography/tandem‐MS is used as a highly accurate method to detect and identify the resulting peptides. A combination of the depicted peptide‐ and protein‐centric approaches, as shown in the center, gives insights into a multitude of biochemical and structural properties of the studied protein assemblies.
Figure 2 The broad scope of complementary biomolecular MS methods In protein‐centric approaches (top), non‐digested biomolecules or biomolecular assemblies are analyzed. Typically, the sample is injected into the mass spectrometer via electrospray ionization using a conductive borosilicate capillary, as symbolized in the top panel. After injection, the analyte structure and composition can be further evaluated by several gas‐phase manipulation strategies, some of which are schematically depicted. Ion mobility separation prior to mass measurement renders information about the analyte's conformation and shape. Dissociation of a non‐denatured biomolecular assembly by collisional activation (symbolized as an explosion cartoon) allows inferring its stoichiometry and topological aspects. Mass selection can be performed for both denatured and non‐denatured analytes, enabling the focused analysis of a specific species such as a protein isoform that carries a certain mutation or a defined number of PTMs. After mass selection, proteoform sequencing can be performed by fragmenting the protein isoforms in the gas phase (symbolized as an explosion cartoon), which allows to determine their amino acid sequence and thus locate mutated and/or modified residues. In peptide‐centric approaches (bottom), proteins or protein complexes are manipulated in solution by traditional biochemical methods, such as chemical cross‐linking, limited proteolysis, or surface labeling. Subsequently, the proteins are digested into peptides and liquid chromatography/tandem‐MS is used as a highly accurate method to detect and identify the resulting peptides. A combination of the depicted peptide‐ and protein‐centric approaches, as shown in the center, gives insights into a multitude of biochemical and structural properties of the studied protein assemblies.CC BY-NC-ND · PubMed Central
Figure 3 Basic principles of biomolecular MS (A) Essential components of a mass spectrometer. The ion source facilitates the transfer of the analyte into the gas phase. The low‐resolution mass analyzer enables mass selection of specific analyte ion species and, in case of ion traps, may also be utilized for ion activation/fragmentation. Otherwise, gas‐phase fragmentation, for example, using CID, HCD, or ETD, takes place in the collision cell. Finally, a high‐resolution FTICR, TOF, or Orbitrap mass analyzer facilitates precise and accurate mass measurements. (B) Schematic representation of ESI and MALDI, the most commonly used ionization techniques in biomolecular MS. ESI produces multiply charged analyte ions (shown in yellow, orange, red, and purple) directly from a sample solution. In MALDI, a laser is used to ablate a mixture of matrix (shown in blue) and analyte molecules from a metal plate into the mass spectrometer, yielding predominantly singly charged ions. (C) Nomenclature of peptide fragment ions according to Roepstorff and Fohlman (1984) and Biemann (1990).
Figure 3 Basic principles of biomolecular MS (A) Essential components of a mass spectrometer. The ion source facilitates the transfer of the analyte into the gas phase. The low‐resolution mass analyzer enables mass selection of specific analyte ion species and, in case of ion traps, may also be utilized for ion activation/fragmentation. Otherwise, gas‐phase fragmentation, for example, using CID, HCD, or ETD, takes place in the collision cell. Finally, a high‐resolution FTICR, TOF, or Orbitrap mass analyzer facilitates precise and accurate mass measurements. (B) Schematic representation of ESI and MALDI, the most commonly used ionization techniques in biomolecular MS. ESI produces multiply charged analyte ions (shown in yellow, orange, red, and purple) directly from a sample solution. In MALDI, a laser is used to ablate a mixture of matrix (shown in blue) and analyte molecules from a metal plate into the mass spectrometer, yielding predominantly singly charged ions. (C) Nomenclature of peptide fragment ions according to Roepstorff and Fohlman (1984) and Biemann (1990).CC BY-NC-ND · PubMed Central
Figure 4 Complementary biomolecular MS data exemplified using the human hemoglobin model system (A) Schematic of native holo‐hemoglobin and its constituents: two α‐chains, two β‐chains, and 4 heme groups. (B) Cross‐linking‐MS. The displayed MS2 spectrum represents two linked peptides derived from cross‐linked holo‐hemoglobin. The ion signals, shown as blue and red sticks, correspond to specific fragments of the cross‐linked peptides. These fragment ions enable the sequencing of both peptides and the localization of their linkage site, as indicated by the fragment ion map in the inset. Since two residues are only cross‐linked if they are in close spatial proximity, the identified cross‐link gives insights into the in‐solution structure of holo‐hemoglobin. (C) HDX‐MS. Shown are the isotope distributions of the same peptide derived from either holo‐hemoglobin (left panel) or the free hemoglobin α‐chain (right panel) after they were separately incubated in D2O‐containing buffer. The incubations were quenched at three different time points. The isotope distribution remains at the same m/z position, when the peptide is derived from holo‐hemoglobin, whereas it gradually moves to higher m/z, when the peptide is derived from the free α‐chain. This shows that only in the free α‐chain, the peptide is able to take up the heavy deuterium isotope. Consequently, the peptide is solvent accessible in the free α‐chain, whereas it is solvent protected in holo‐hemoglobin. (D) Protein‐centric MS. Mass spectra of non‐digested hemoglobin were acquired under denaturing (upper mass spectrum) and native (lower mass spectrum) conditions. Under denaturing conditions, all signals are concentrated in the low m/z region since the ions of the unfolded proteins are highly charged. The inset illustrates that the heme cofactor is present as a singly charged ion (brown), whereas the hemoglobin α‐chain (red) and β‐chain (blue) are detected in several charge states. From these charge state envelopes, their accurate molecular masses can be derived (α‐chain = 15,155 ± 1 Da, β‐chain = 15,895 ± 1 Da, heme = 616.5 Da). In the native mass spectrum, the signals are shifted to higher m/z, indicating that hemoglobin is detected in its folded state (see main text). The molecular weight can be calculated as 64,588 ± 41 Da. Together with the constituent masses derived from the denaturing MS experiment, this result unambiguously evidences that holo‐hemoglobin is an α2β2 heterotetramer with four bound heme ligands.
Figure 4 Complementary biomolecular MS data exemplified using the human hemoglobin model system (A) Schematic of native holo‐hemoglobin and its constituents: two α‐chains, two β‐chains, and 4 heme groups. (B) Cross‐linking‐MS. The displayed MS2 spectrum represents two linked peptides derived from cross‐linked holo‐hemoglobin. The ion signals, shown as blue and red sticks, correspond to specific fragments of the cross‐linked peptides. These fragment ions enable the sequencing of both peptides and the localization of their linkage site, as indicated by the fragment ion map in the inset. Since two residues are only cross‐linked if they are in close spatial proximity, the identified cross‐link gives insights into the in‐solution structure of holo‐hemoglobin. (C) HDX‐MS. Shown are the isotope distributions of the same peptide derived from either holo‐hemoglobin (left panel) or the free hemoglobin α‐chain (right panel) after they were separately incubated in D2O‐containing buffer. The incubations were quenched at three different time points. The isotope distribution remains at the same m/z position, when the peptide is derived from holo‐hemoglobin, whereas it gradually moves to higher m/z, when the peptide is derived from the free α‐chain. This shows that only in the free α‐chain, the peptide is able to take up the heavy deuterium isotope. Consequently, the peptide is solvent accessible in the free α‐chain, whereas it is solvent protected in holo‐hemoglobin. (D) Protein‐centric MS. Mass spectra of non‐digested hemoglobin were acquired under denaturing (upper mass spectrum) and native (lower mass spectrum) conditions. Under denaturing conditions, all signals are concentrated in the low m/z region since the ions of the unfolded proteins are highly charged. The inset illustrates that the heme cofactor is present as a singly charged ion (brown), whereas the hemoglobin α‐chain (red) and β‐chain (blue) are detected in several charge states. From these charge state envelopes, their accurate molecular masses can be derived (α‐chain = 15,155 ± 1 Da, β‐chain = 15,895 ± 1 Da, heme = 616.5 Da). In the native mass spectrum, the signals are shifted to higher m/z, indicating that hemoglobin is detected in its folded state (see main text). The molecular weight can be calculated as 64,588 ± 41 Da. Together with the constituent masses derived from the denaturing MS experiment, this result unambiguously evidences that holo‐hemoglobin is an α2β2 heterotetramer with four bound heme ligands.CC BY-NC-ND · PubMed Central
Figure 5 Hybrid approaches gradually unravel the Mediator complex architecture The Mediator complex is a challenging target for structural biology because it comprises several subcomplexes and highly flexible regions. First, a topological model of the Mediator middle module was derived with a hybrid approach employing native MS and IMS‐MS. This could be extended to a more detailed model by means of cross‐linking‐MS and homology modeling. In parallel, a Mediator head module structure was derived by combining X‐ray crystallography and cross‐linking‐MS results. Finally, hybrid structural biology approaches led to the characterization of a 15‐subunit Mediator core complex and a 21‐subunit Mediator complex. Structural images adapted with permission from the publications referenced in the figure.
Figure 5 Hybrid approaches gradually unravel the Mediator complex architecture The Mediator complex is a challenging target for structural biology because it comprises several subcomplexes and highly flexible regions. First, a topological model of the Mediator middle module was derived with a hybrid approach employing native MS and IMS‐MS. This could be extended to a more detailed model by means of cross‐linking‐MS and homology modeling. In parallel, a Mediator head module structure was derived by combining X‐ray crystallography and cross‐linking‐MS results. Finally, hybrid structural biology approaches led to the characterization of a 15‐subunit Mediator core complex and a 21‐subunit Mediator complex. Structural images adapted with permission from the publications referenced in the figure.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Items 201–270 of 270

Research works printed but not linked: 2

  1. Clemmer DE, Jarrold MF (1997) Ion mobility measurements and their applications to clusters and biomolecules. J Mass Spectrom 32: 577–592 · DOI · Paper page
  2. Cooks RG, Rockwood AL (1991) Letters to the editor The ‘Thomson’. A suggested unit for mass spectroscopists. Rapid Commun Mass Spectrom 5: 93

Cited by

See all 224

Metadata

Authors
Lössl, P., van de Waterbeemd, M., & Heck, A. J.
Affiliations
Utrecht University (NL)
Corresponding author
Heck, Albert JR
Venue
The EMBO Journal
Published
2016-10-26
Volume
35
Issue
24
Pages
2634-2657
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2543713321
Cited by
222
References
271
Citations by year
2026: 5 · 2025: 6 · 2024: 5 · 2023: 16 · 2022: 24 · 2021: 35 · 2020: 25 · 2019: 43 · 2018: 26 · 2017: 32 · 2016: 3
FWCI
3.55
Type
journal article
Language
en
Open access
Licence
Locations
  • The EMBO Journal (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
Funders
  • Netherlands Organization for Scientific Research (184.032.201)
  • European Union's Horizon 2020 Programme (686547)
  • European Union 7th Framework Programme (317371)
  • Stichtung voor Fundamenteel Onderzoek der Materie (12PR3303‐2)
Topics
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
  • Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
Keywords
mass spectrometry, structural biology, molecular biology, native mass spectrometry, cross-linking mass spectrometry, hydrogen-deuterium exchange mass spectrometry, biomolecular interactions, macromolecular complexes, CRISPR-Cas, proteomics
MeSH terms
Molecular Biology, Mass Spectrometry, Macromolecular Substances

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.